non fda approved glp 1 Pharmacovigilance Assessment of Compounded GLP-1 Receptor Agonists: Insights From the Adverse Event Reporting System Key FDA approval (April 2026)

Once hailed solely as a game-changer in weight loss and diabetes management, GLP-1 drugs like Ozempic, Wegovy, and Zepbound are now generating buzz for a much broader range of potential health benefits

Figure 24 shows the level of mouse VEGF in sera from tumor-bearing mice that were treated with control IgG, avastin, 2C3 or r84 (as indicated)

6 Similarly, as GLP-1RAs significantly reduced the risk of MACE, mortality from CV causes, when compared with placebo, ADA has suggested that these medications should be used in patients with underlying cardiovascular disease

"Most people are not aware of its risks, including potentially serious, drug-drug interactions, Spiller added